PYRIDOSTIGMINE BROMIDE

PYRIDOSTIGMINE BROMIDE was reported 7627 times

PYRIDOSTIGMINE BROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MORVAN SYNDROME 6 0.4615
1 CONGENITAL MYASTHENIC SYNDROME 5 0.2381
2 ADIPOSIS DOLOROSA 11 0.2292
3 INTESTINAL TRANSIT TIME DECREASED 11 0.1429
4 MYASTHENIA GRAVIS CRISIS 173 0.1167
5 MYASTHENIA GRAVIS 878 0.1086
6 MYASTHENIC SYNDROME 80 0.1034
7 THYMECTOMY 9 0.1023
8 ANTIACETYLCHOLINE RECEPTOR ANTIBODY POSITIVE 7 0.0933
9 THYMOMA 30 0.0831
10 OCULAR MYASTHENIA 17 0.0496
11 PROCEDURAL HEADACHE 16 0.0390
12 CHOLINERGIC SYNDROME 21 0.0329
13 PLASMAPHERESIS 15 0.0287
14 AVERSION 7 0.0243
15 MORPHOEA 10 0.0207
16 EYELID PTOSIS 190 0.0187
17 B-CELL LYMPHOMA RECURRENT 10 0.0184
18 DIAPHRAGMATIC PARALYSIS 11 0.0184
19 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 23 0.0170
20 EHLERS-DANLOS SYNDROME 7 0.0151
21 WRONG PATIENT RECEIVED PRODUCT 38 0.0130
22 MASTICATION DISORDER 36 0.0117
23 DIPLOPIA 296 0.0114
24 FAECAL VOMITING 6 0.0113
25 SYMPTOM RECURRENCE 66 0.0110
26 INFUSION SITE URTICARIA 7 0.0104
27 OPHTHALMOPLEGIA 16 0.0101
28 NEUROMYOPATHY 10 0.0094
29 MUSCLE DISCOMFORT 7 0.0089
30 SARS-COV-2 TEST NEGATIVE 6 0.0089
31 INFUSION SITE DISCHARGE 15 0.0085
32 VERTEBRAL FORAMINAL STENOSIS 7 0.0085
33 MENINGITIS ASEPTIC 38 0.0085
34 SOLAR LENTIGO 8 0.0084
35 CYANOPSIA 5 0.0083
36 SYSTEMIC SCLERODERMA 6 0.0082
37 NECROTISING MYOSITIS 7 0.0081
38 SERRATIA INFECTION 6 0.0081
39 DIAPHRAGMATIC DISORDER 6 0.0078
40 MAST CELL ACTIVATION SYNDROME 11 0.0078
41 RESTRICTIVE PULMONARY DISEASE 9 0.0077
42 BONE CONTUSION 7 0.0076
43 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 7 0.0076
44 BLOOD IMMUNOGLOBULIN G INCREASED 9 0.0074
45 PARAESTHESIA ORAL 105 0.0073
46 PRINZMETAL ANGINA 7 0.0070
47 TONGUE MOVEMENT DISTURBANCE 6 0.0070
48 MYOCARDIAL NECROSIS MARKER INCREASED 11 0.0066
49 OPHTHALMIC HERPES ZOSTER 11 0.0061
50 INFUSION SITE BRUISING 12 0.0056
51 INFUSION SITE IRRITATION 7 0.0054
52 MUSCLE FATIGUE 23 0.0054
53 MUSCLE CONTRACTIONS INVOLUNTARY 19 0.0054
54 THERAPEUTIC RESPONSE DELAYED 15 0.0054
55 INFUSION SITE HAEMORRHAGE 17 0.0052
56 STRABISMUS 15 0.0051
57 MENOPAUSE 13 0.0050
58 AUTONOMIC NEUROPATHY 5 0.0049
59 RESPIRATORY ALKALOSIS 8 0.0049
60 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 7 0.0049
61 ALLERGY TO CHEMICALS 6 0.0048
62 CONSCIOUSNESS FLUCTUATING 5 0.0048
63 PANCREATIC ENZYMES INCREASED 7 0.0048
64 ORAL FUNGAL INFECTION 13 0.0047
65 MECHANICAL VENTILATION 9 0.0047
66 EYE CONTUSION 10 0.0047
67 INSURANCE ISSUE 71 0.0046
68 MEDICATION RESIDUE PRESENT 22 0.0046
69 HAEMATOLOGICAL INFECTION 11 0.0045
70 CARBON DIOXIDE INCREASED 6 0.0044
71 PRODUCT RESIDUE PRESENT 23 0.0043
72 BLOOD IMMUNOGLOBULIN G DECREASED 10 0.0040
73 FACIAL PARESIS 14 0.0040
74 BLOOD PRESSURE DIASTOLIC ABNORMAL 10 0.0039
75 GASTRIC INFECTION 15 0.0039
76 PNEUMONIA PSEUDOMONAL 6 0.0039
77 EYELID DISORDER 9 0.0039
78 GASTROINTESTINAL STOMA COMPLICATION 6 0.0038
79 SALIVARY HYPERSECRETION 38 0.0038
80 DYSPNOEA AT REST 11 0.0038
81 ESCHERICHIA URINARY TRACT INFECTION 16 0.0038
82 SUSPECTED COVID-19 12 0.0036
83 MUSCULAR WEAKNESS 410 0.0036
84 ENDOTRACHEAL INTUBATION 10 0.0036
85 BRAIN ABSCESS 9 0.0036
86 INCREASED BRONCHIAL SECRETION 9 0.0035
87 INFUSION SITE PRURITUS 11 0.0035
88 BLOOD CHLORIDE INCREASED 6 0.0035
89 POOR VENOUS ACCESS 35 0.0034
90 BLEPHAROSPASM 21 0.0033
91 CENTRAL VENOUS CATHETERISATION 10 0.0033
92 OPTIC NEUROPATHY 7 0.0033
93 CLUMSINESS 9 0.0033
94 THERAPEUTIC RESPONSE SHORTENED 109 0.0033
95 RASH MORBILLIFORM 9 0.0032
96 GASTROINTESTINAL TUBE INSERTION 8 0.0032
97 WALKING AID USER 21 0.0032
98 HYPOAESTHESIA ORAL 48 0.0032
99 WHEELCHAIR USER 14 0.0031
100 PARESIS 7 0.0031
101 THERAPEUTIC PRODUCT EFFECT VARIABLE 12 0.0031
102 THERAPEUTIC PRODUCT EFFECT DELAYED 14 0.0031
103 APLASIA 6 0.0031
104 IMMUNOSUPPRESSION 27 0.0031
105 DYSPHAGIA 285 0.0030
106 DYSARTHRIA 111 0.0029
107 CHOKING 57 0.0029
108 PARANASAL SINUS DISCOMFORT 11 0.0029
109 INFUSION SITE EXTRAVASATION 18 0.0029
110 NEUROGENIC BLADDER 6 0.0028
111 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
112 DEVICE INFUSION ISSUE 7 0.0028
113 THERMAL BURN 20 0.0028
114 RESPIRATORY ACIDOSIS 11 0.0028
115 LUMBAR SPINAL STENOSIS 8 0.0027
116 PRE-EXISTING CONDITION IMPROVED 17 0.0027
117 ELECTROCARDIOGRAM T WAVE INVERSION 6 0.0027
118 THERAPEUTIC PRODUCT INEFFECTIVE 10 0.0026
119 ASTHENOPIA 14 0.0025
120 MENINGITIS 17 0.0025
121 HORDEOLUM 11 0.0025
122 DROOLING 17 0.0025
123 LYMPHOCYTE COUNT INCREASED 8 0.0024
124 BLOOD PRESSURE DIASTOLIC DECREASED 18 0.0024
125 SPINAL STENOSIS 10 0.0024
126 VEIN DISORDER 12 0.0024
127 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7 0.0024
128 POTENTIATING DRUG INTERACTION 8 0.0024
129 INCORRECT DRUG ADMINISTRATION RATE 10 0.0023
130 THERAPY CHANGE 23 0.0023
131 MEAN CELL VOLUME INCREASED 6 0.0023
132 PHYSICAL DECONDITIONING 6 0.0023
133 HYPERCAPNIA 7 0.0023
134 CATHETER SITE PAIN 6 0.0023
135 PERSONALITY DISORDER 6 0.0023
136 OESOPHAGEAL CANDIDIASIS 9 0.0023
137 INFUSION SITE ERYTHEMA 19 0.0023
138 VITAMIN B12 DEFICIENCY 9 0.0022
139 ORTHOPNOEA 7 0.0022
140 STOMA SITE DISCHARGE 6 0.0022
141 PRODUCT ADMINISTRATION INTERRUPTED 17 0.0022
142 CHOLECYSTITIS INFECTIVE 6 0.0022
143 DRUG EFFECT LESS THAN EXPECTED 32 0.0022
144 PRODUCT DISTRIBUTION ISSUE 20 0.0022
145 ELECTRIC SHOCK SENSATION 6 0.0021
146 PRODUCT COLOUR ISSUE 11 0.0021
147 PERIPHERAL COLDNESS 29 0.0021
148 BLOOD PRESSURE FLUCTUATION 50 0.0021
149 SPEECH DISORDER 109 0.0021
150 HYPERTONIC BLADDER 6 0.0021
151 INFUSION SITE SWELLING 13 0.0021
152 RHINOVIRUS INFECTION 8 0.0021
153 APNOEA 16 0.0021
154 COMPRESSION FRACTURE 11 0.0021
155 AUTOIMMUNE DISORDER 20 0.0020
156 ENTERITIS 13 0.0020
157 SKIN LACERATION 22 0.0020
158 BLOOD IRON DECREASED 24 0.0020
159 HAEMOGLOBIN ABNORMAL 13 0.0020
160 HYPOPNOEA 7 0.0020
161 EAR PRURITUS 7 0.0020
162 ARTERIOSPASM CORONARY 8 0.0020
163 PULMONARY MASS 29 0.0019
164 PNEUMONIA ASPIRATION 48 0.0019
165 UTERINE LEIOMYOMA 14 0.0019
166 BRAIN FOG 30 0.0019
167 FACIAL PAIN 17 0.0019
168 EYE MOVEMENT DISORDER 13 0.0019
169 BLOOD PRESSURE SYSTOLIC INCREASED 37 0.0019
170 FEBRILE BONE MARROW APLASIA 8 0.0019
171 ANIMAL BITE 5 0.0019
172 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
173 ATELECTASIS 18 0.0019
174 DECREASED ACTIVITY 20 0.0019
175 UROSEPSIS 17 0.0018
176 DERMATITIS CONTACT 21 0.0018
177 PHARYNGEAL SWELLING 18 0.0018
178 DYSPNOEA EXERTIONAL 69 0.0018
179 ONYCHOMYCOSIS 8 0.0018
180 INTENTIONAL PRODUCT USE ISSUE 158 0.0018
181 LYME DISEASE 6 0.0018
182 INFUSION SITE PAIN 23 0.0018
183 PRODUCT SOLUBILITY ABNORMAL 9 0.0018
184 SLEEP APNOEA SYNDROME 34 0.0018
185 NEOPLASM RECURRENCE 6 0.0018
186 VASCULAR DEVICE INFECTION 8 0.0018
187 NEUTROPHIL COUNT INCREASED 18 0.0018
188 CEREBRAL ATROPHY 7 0.0018
189 APLASIA PURE RED CELL 6 0.0017
190 ASPIRATION 19 0.0017
191 FUNGAL SKIN INFECTION 7 0.0017
192 BURSITIS 21 0.0017
193 MUSCLE DISORDER 14 0.0017
194 URINE OUTPUT DECREASED 15 0.0017
195 SEASONAL ALLERGY 24 0.0017
196 CARDIAC PACEMAKER INSERTION 10 0.0017
197 HYPOGAMMAGLOBULINAEMIA 11 0.0017
198 MICTURITION URGENCY 19 0.0017
199 SPONDYLITIS 6 0.0016
200 DYSSTASIA 48 0.0016
201 ATRIOVENTRICULAR BLOCK COMPLETE 11 0.0016
202 ASTHENIA 614 0.0016
203 ON AND OFF PHENOMENON 9 0.0016
204 HYPERVOLAEMIA 8 0.0016
205 LIMB DISCOMFORT 50 0.0016
206 FRUSTRATION TOLERANCE DECREASED 13 0.0016
207 INCONTINENCE 17 0.0016
208 CHRONIC SINUSITIS 6 0.0016
209 BLOOD CREATININE DECREASED 5 0.0016
210 SPINAL OSTEOARTHRITIS 14 0.0016
211 VIRAL INFECTION 53 0.0016
212 ABDOMINAL ABSCESS 7 0.0016
213 GASTROENTERITIS 23 0.0016
214 RIGHT VENTRICULAR FAILURE 11 0.0016
215 MUSCLE TWITCHING 36 0.0016
216 ENDOCARDITIS 8 0.0016
217 SENSORY DISTURBANCE 25 0.0016
218 ANAL INCONTINENCE 14 0.0016
219 DIVERTICULITIS 43 0.0016
220 CONCUSSION 12 0.0015
221 REHABILITATION THERAPY 6 0.0015
222 DIZZINESS POSTURAL 15 0.0015
223 EAR INFECTION 41 0.0015
224 VITAMIN D DEFICIENCY 15 0.0015
225 HAEMOGLOBIN INCREASED 7 0.0015
226 HEAD INJURY 48 0.0015
227 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
228 PHOTOPHOBIA 28 0.0015
229 ENURESIS 6 0.0015
230 POISONING DELIBERATE 14 0.0015
231 ARTHRITIS BACTERIAL 6 0.0015
232 TEMPERATURE INTOLERANCE 15 0.0015
233 EUGLYCAEMIC DIABETIC KETOACIDOSIS 6 0.0015
234 HUMERUS FRACTURE 7 0.0015
235 SECRETION DISCHARGE 18 0.0014
236 LEUKOCYTOSIS 26 0.0014
237 BOWEL MOVEMENT IRREGULARITY 11 0.0014
238 SKIN INFECTION 16 0.0014
239 LOW DENSITY LIPOPROTEIN INCREASED 11 0.0014
240 PANCREATIC DISORDER 7 0.0014
241 RESPIRATORY TRACT INFECTION 37 0.0014
242 PARAESTHESIA 223 0.0014
243 PELVIC FRACTURE 11 0.0014
244 GASTROINTESTINAL SOUNDS ABNORMAL 7 0.0014
245 RIB FRACTURE 29 0.0014
246 FACIAL PARALYSIS 12 0.0014
247 THROAT TIGHTNESS 38 0.0014
248 MULTIPLE ALLERGIES 11 0.0014
249 APPENDICECTOMY 5 0.0014
250 PSEUDOMONAS INFECTION 12 0.0014
251 HEREDITARY ANGIOEDEMA 15 0.0014
252 PRESCRIBED OVERDOSE 27 0.0014
253 INCOHERENT 9 0.0014
254 RENAL CYST 11 0.0014
255 BACK INJURY 15 0.0014
256 RESPIRATORY DISTRESS 38 0.0014
257 MOTOR DYSFUNCTION 14 0.0014
258 MIOSIS 11 0.0014
259 CYST 17 0.0014
260 CELLULITIS 69 0.0014
261 PERIPHERAL SENSORY NEUROPATHY 8 0.0014
262 DYSPHEMIA 6 0.0014
263 RHINITIS 11 0.0014
264 CORONAVIRUS INFECTION 9 0.0014
265 URINARY TRACT INFECTION 232 0.0014
266 BLINDNESS TRANSIENT 10 0.0014
267 BRADYKINESIA 8 0.0014
268 AMYLASE INCREASED 5 0.0014
269 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
270 ARTHROPOD BITE 10 0.0013
271 MUSCLE ATROPHY 17 0.0013
272 MYOSITIS 12 0.0013
273 WRIST FRACTURE 16 0.0013
274 URINARY TRACT DISORDER 6 0.0013
275 ULCER HAEMORRHAGE 9 0.0013
276 FEELING COLD 37 0.0013
277 HEMIPLEGIA 11 0.0013
278 BODY TEMPERATURE DECREASED 13 0.0013
279 BONE DISORDER 24 0.0013
280 INABILITY TO AFFORD MEDICATION 13 0.0013
281 BALANCE DISORDER 113 0.0013
282 LIPASE INCREASED 10 0.0013
283 POOR QUALITY SLEEP 28 0.0013
284 RESPIRATORY FAILURE 94 0.0013
285 PRODUCT PHYSICAL ISSUE 26 0.0013
286 NECK PAIN 72 0.0013
287 BLOOD PRESSURE INCREASED 196 0.0013
288 SPINAL PAIN 15 0.0013
289 GASTROINTESTINAL PAIN 14 0.0013
290 PHARMACEUTICAL PRODUCT COMPLAINT 33 0.0013
291 RESPIRATORY DISORDER 38 0.0013
292 HYPERKERATOSIS 7 0.0013
293 OXYGEN SATURATION DECREASED 71 0.0013
294 COLD SWEAT 22 0.0012
295 CANDIDIASIS 5 0.0012
296 TONGUE DISORDER 9 0.0012
297 COMA 59 0.0012
298 MUSCULOSKELETAL DISCOMFORT 21 0.0012
299 GASTROENTERITIS VIRAL 22 0.0012
300 EYE DISORDER 40 0.0012
301 URINARY INCONTINENCE 36 0.0012
302 DIABETIC NEUROPATHY 6 0.0012
303 ABDOMINAL TENDERNESS 6 0.0012
304 HYPOTONIA 12 0.0012
305 DERMATITIS EXFOLIATIVE 6 0.0012
306 WHITE BLOOD CELL COUNT INCREASED 46 0.0012
307 PRODUCT SUBSTITUTION ISSUE 68 0.0012
308 BACTERIAL INFECTION 22 0.0012
309 IMPAIRED GASTRIC EMPTYING 16 0.0012
310 BRADYCARDIA 62 0.0012
311 FALL 389 0.0012
312 FOOD ALLERGY 9 0.0012
313 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 56 0.0012
314 MUSCULOSKELETAL CHEST PAIN 18 0.0012
315 DYSPHONIA 68 0.0012
316 TRISMUS 6 0.0012
317 VARICOSE VEIN 6 0.0012
318 OCULAR DISCOMFORT 13 0.0012
319 MITRAL VALVE INCOMPETENCE 13 0.0011
320 APHONIA 16 0.0011
321 COVID-19 201 0.0011
322 ACUTE RESPIRATORY FAILURE 22 0.0011
323 IMMUNODEFICIENCY 17 0.0011
324 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
325 SERUM FERRITIN INCREASED 6 0.0011
326 GAIT DISTURBANCE 217 0.0011
327 DIVERTICULUM 8 0.0011
328 UPPER RESPIRATORY TRACT INFECTION 52 0.0011
329 SWELLING OF EYELID 7 0.0011
330 ERYTHEMA OF EYELID 6 0.0011
331 GAIT INABILITY 37 0.0011
332 BLOOD PRESSURE ABNORMAL 22 0.0011
333 DECUBITUS ULCER 9 0.0011
334 BLOOD THYROID STIMULATING HORMONE DECREASED 5 0.0011
335 PRODUCT AVAILABILITY ISSUE 25 0.0011
336 WOUND INFECTION 12 0.0011
337 JAW DISORDER 6 0.0011
338 ESCHERICHIA INFECTION 9 0.0011
339 APHASIA 33 0.0011
340 SPINAL COMPRESSION FRACTURE 9 0.0011
341 PROSTATIC DISORDER 6 0.0011
342 INFUSION RELATED REACTION 72 0.0011
343 SYRINGE ISSUE 19 0.0011
344 UNRESPONSIVE TO STIMULI 28 0.0011
345 NERVE COMPRESSION 10 0.0011
346 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
347 HAEMATOMA 28 0.0011
348 MUSCLE SPASMS 198 0.0011
349 ARTHRITIS INFECTIVE 5 0.0011
350 ANGIOPATHY 6 0.0011
351 HAND DEFORMITY 14 0.0011
352 SINUSITIS 109 0.0011
353 ORAL CANDIDIASIS 14 0.0011
354 GASTROINTESTINAL DISORDER 95 0.0011
355 CHOLECYSTITIS ACUTE 6 0.0011
356 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
357 UPPER LIMB FRACTURE 21 0.0011
358 WEIGHT FLUCTUATION 11 0.0011
359 PSYCHOTIC DISORDER 31 0.0010
360 PARALYSIS 15 0.0010
361 NEPHROLITHIASIS 48 0.0010
362 MYOPATHY 9 0.0010
363 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 74 0.0010
364 AFFECT LABILITY 10 0.0010
365 BRONCHIECTASIS 7 0.0010
366 PYELONEPHRITIS 9 0.0010
367 GLAUCOMA 20 0.0010
368 ELECTROLYTE IMBALANCE 12 0.0010
369 STRESS CARDIOMYOPATHY 6 0.0010
370 BLOOD POTASSIUM DECREASED 31 0.0010
371 LIMB INJURY 28 0.0010
372 DELUSION 16 0.0010
373 OSTEOPOROSIS 42 0.0010
374 RESPIRATION ABNORMAL 7 0.0010
375 RESPIRATORY RATE INCREASED 9 0.0010
376 HYPERSOMNIA 29 0.0010
377 BACTERAEMIA 12 0.0010
378 HERPES ZOSTER 58 0.0010
379 HAEMATOCRIT DECREASED 20 0.0010
380 FATIGUE 781 0.0010
381 FLUID RETENTION 51 0.0010
382 PLATELET COUNT INCREASED 13 0.0010
383 HYPOKALAEMIA 46 0.0010
384 GAMMA-GLUTAMYLTRANSFERASE INCREASED 22 0.0010
385 LOCALISED INFECTION 24 0.0010
386 STENT PLACEMENT 8 0.0010
387 LIP SWELLING 33 0.0010
388 CATARACT 59 0.0010
389 RHINORRHOEA 64 0.0010
390 FUNGAL INFECTION 33 0.0010
391 LYMPHOPENIA 14 0.0010
392 CHILLS 116 0.0010
393 URINARY RETENTION 33 0.0010
394 NOCTURIA 12 0.0010
395 HAND FRACTURE 7 0.0010
396 POST PROCEDURAL INFECTION 8 0.0010
397 ORTHOSTATIC HYPOTENSION 17 0.0010
398 MOBILITY DECREASED 70 0.0010
399 ORAL HERPES 19 0.0010
400 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
401 CONJUNCTIVITIS 18 0.0010
402 HALLUCINATION 73 0.0010
403 AGRANULOCYTOSIS 18 0.0010
404 PHARYNGITIS 12 0.0010
405 THINKING ABNORMAL 18 0.0010
406 CHOLECYSTECTOMY 11 0.0010
407 CLOSTRIDIUM DIFFICILE INFECTION 21 0.0010
408 INTERVERTEBRAL DISC PROTRUSION 21 0.0010
409 THERAPEUTIC PRODUCT EFFECT DECREASED 43 0.0010
410 APLASTIC ANAEMIA 5 0.0010
411 VISION BLURRED 131 0.0010
412 SUDDEN DEATH 10 0.0009
413 RESPIRATORY ARREST 26 0.0009
414 CYSTITIS 30 0.0009
415 HYPOAESTHESIA 141 0.0009
416 SCREAMING 6 0.0009
417 SCIATICA 15 0.0009
418 EATING DISORDER 20 0.0009
419 DYSPNOEA 529 0.0009
420 THERAPY NON-RESPONDER 42 0.0009
421 MIGRAINE 89 0.0009
422 INFLUENZA 103 0.0009
423 HIP ARTHROPLASTY 14 0.0009
424 BLOOD CALCIUM INCREASED 8 0.0009
425 PRODUCT DOSE OMISSION ISSUE 268 0.0009
426 HEART RATE DECREASED 32 0.0009
427 PULMONARY CONGESTION 12 0.0009
428 ATRIOVENTRICULAR BLOCK 7 0.0009
429 CONDITION AGGRAVATED 275 0.0009
430 RED BLOOD CELL SEDIMENTATION RATE INCREASED 10 0.0009
431 ABDOMINAL PAIN UPPER 185 0.0009
432 LUNG DISORDER 44 0.0009
433 FOOT FRACTURE 17 0.0009
434 BLOOD UREA INCREASED 15 0.0009
435 CARDIOMEGALY 11 0.0009
436 NEEDLE ISSUE 26 0.0009
437 HAEMOLYTIC ANAEMIA 8 0.0009
438 FEELING JITTERY 17 0.0009
439 GENERALISED OEDEMA 11 0.0009
440 EYE INFECTION 10 0.0009
441 TOOTH ABSCESS 9 0.0009
442 THERAPY INTERRUPTED 63 0.0009
443 HERNIA 17 0.0009
444 BLOOD TESTOSTERONE DECREASED 6 0.0009
445 INITIAL INSOMNIA 9 0.0009
446 DIARRHOEA 566 0.0009
447 MOVEMENT DISORDER 28 0.0009
448 RETINAL DETACHMENT 8 0.0009
449 SENSORY LOSS 7 0.0009
450 INCREASED TENDENCY TO BRUISE 8 0.0009
451 ANAPHYLACTIC REACTION 48 0.0009
452 LYMPHOEDEMA 6 0.0009
453 HAIR GROWTH ABNORMAL 6 0.0009
454 OEDEMA 47 0.0009
455 ARTHRITIS 68 0.0009
456 MUSCLE TIGHTNESS 14 0.0009
457 PRESYNCOPE 21 0.0009
458 NEURALGIA 21 0.0009
459 PETECHIAE 9 0.0009
460 HYPERHIDROSIS 111 0.0009
461 LACRIMATION INCREASED 26 0.0009
462 BLOOD PRESSURE DECREASED 57 0.0009
463 ASPHYXIA 7 0.0009
464 HEADACHE 537 0.0009
465 HYPERKALAEMIA 30 0.0009
466 ILLNESS 88 0.0009
467 CONTUSION 82 0.0009
468 JOINT DISLOCATION 9 0.0009
469 BRONCHITIS 63 0.0009
470 ARTERIOSCLEROSIS 8 0.0008
471 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
472 COVID-19 PNEUMONIA 10 0.0008
473 ACUTE CORONARY SYNDROME 7 0.0008
474 BLOOD URINE PRESENT 16 0.0008
475 CATARACT OPERATION 5 0.0008
476 GASTRIC ULCER 16 0.0008
477 INTENTIONAL DOSE OMISSION 24 0.0008
478 TREATMENT NONCOMPLIANCE 46 0.0008
479 TENDONITIS 13 0.0008
480 VERTIGO 51 0.0008
481 HEPATIC ENZYME INCREASED 57 0.0008
482 POLYNEUROPATHY 10 0.0008
483 TOOTH INFECTION 11 0.0008
484 GLYCOSYLATED HAEMOGLOBIN INCREASED 21 0.0008
485 THROAT IRRITATION 37 0.0008
486 MUSCULOSKELETAL STIFFNESS 72 0.0008
487 STAPHYLOCOCCAL INFECTION 27 0.0008
488 SINUS CONGESTION 11 0.0008
489 SENSITIVE SKIN 6 0.0008
490 SPINAL OPERATION 10 0.0008
491 LIGAMENT SPRAIN 8 0.0008
492 TACHYPNOEA 11 0.0008
493 HYSTERECTOMY 7 0.0008
494 SLEEP DISORDER 57 0.0008
495 FEELING DRUNK 6 0.0008
496 ILL-DEFINED DISORDER 49 0.0008
497 BLADDER DISORDER 8 0.0008
498 RED BLOOD CELL COUNT DECREASED 23 0.0008
499 JOINT STIFFNESS 21 0.0008
500 BACK DISORDER 13 0.0008
501 THERAPY CESSATION 41 0.0008
502 C-REACTIVE PROTEIN INCREASED 29 0.0008
503 HEART RATE IRREGULAR 18 0.0008
504 GRIP STRENGTH DECREASED 7 0.0008
505 INFLAMMATION 41 0.0008
506 TOXIC SKIN ERUPTION 8 0.0008
507 PROCEDURAL PAIN 22 0.0008
508 FEELING ABNORMAL 190 0.0008
509 LYMPHOCYTE COUNT DECREASED 14 0.0008
510 THERAPEUTIC RESPONSE DECREASED 48 0.0008
511 PRODUCT ADMINISTRATION ERROR 16 0.0008
512 TOXIC EPIDERMAL NECROLYSIS 12 0.0008
513 PHOTOSENSITIVITY REACTION 13 0.0008
514 WOUND 22 0.0008
515 ABDOMINAL DISCOMFORT 132 0.0008
516 MYOCARDITIS 9 0.0008
517 SLUGGISHNESS 8 0.0008
518 THIRST 14 0.0008
519 VISUAL IMPAIRMENT 97 0.0008
520 MYALGIA 133 0.0008
521 GASTROINTESTINAL INFECTION 7 0.0008
522 UNEVALUABLE EVENT 59 0.0008
523 HAEMOLYSIS 6 0.0008
524 OROPHARYNGEAL DISCOMFORT 7 0.0008
525 DIABETES MELLITUS 59 0.0008
526 SKIN ULCER 20 0.0008
527 OSTEOMYELITIS 14 0.0008
528 EAR PAIN 15 0.0008
529 SEPSIS 86 0.0008
530 WEIGHT DECREASED 215 0.0008
531 HAEMORRHOIDS 15 0.0008
532 WEIGHT INCREASED 172 0.0008
533 BACK PAIN 178 0.0008
534 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
535 PRODUCT USE COMPLAINT 12 0.0008
536 ANOSMIA 11 0.0008
537 LEUKOPENIA 38 0.0008
538 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
539 IMMUNE SYSTEM DISORDER 10 0.0008
540 HYPOKINESIA 11 0.0008
541 COMPLICATION ASSOCIATED WITH DEVICE 11 0.0008
542 SARS-COV-2 TEST POSITIVE 10 0.0008
543 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 136 0.0008
544 PRODUCTIVE COUGH 36 0.0008
545 ABSCESS 12 0.0008
546 HEPATIC STEATOSIS 14 0.0008
547 FLANK PAIN 7 0.0007
548 NEUROPATHY PERIPHERAL 71 0.0007
549 INFECTION 108 0.0007
550 DRUG INTOLERANCE 72 0.0007
551 ABORTION INDUCED 7 0.0007
552 NASOPHARYNGITIS 137 0.0007
553 EOSINOPHILIA 13 0.0007
554 THERAPEUTIC RESPONSE UNEXPECTED 33 0.0007
555 POLYURIA 6 0.0007
556 POST PROCEDURAL COMPLICATION 14 0.0007
557 TREMOR 121 0.0007
558 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 6 0.0007
559 DEEP VEIN THROMBOSIS 47 0.0007
560 MALAISE 317 0.0007
561 SOMNOLENCE 145 0.0007
562 MEDICATION ERROR 40 0.0007
563 NERVE INJURY 8 0.0007
564 HUNGER 10 0.0007
565 MALNUTRITION 8 0.0007
566 LETHARGY 41 0.0007
567 KNEE ARTHROPLASTY 15 0.0007
568 BLOOD CALCIUM DECREASED 8 0.0007
569 PNEUMONIA 230 0.0007
570 LOSS OF CONSCIOUSNESS 91 0.0007
571 HYPOXIA 25 0.0007
572 SYNCOPE 71 0.0007
573 HOSPICE CARE 7 0.0007
574 ATRIAL FIBRILLATION 69 0.0007
575 DISABILITY 14 0.0007
576 IMPAIRED DRIVING ABILITY 8 0.0007
577 HOSPITALISATION 108 0.0007
578 CYANOSIS 11 0.0007
579 FIBROMYALGIA 17 0.0007
580 HYPOTENSION 140 0.0007
581 NASAL CONGESTION 41 0.0007
582 SHOCK 16 0.0007
583 BLOOD MAGNESIUM DECREASED 6 0.0007
584 INJECTION SITE INDURATION 9 0.0007
585 DIZZINESS 344 0.0007
586 FRACTURE 13 0.0007
587 COGNITIVE DISORDER 32 0.0007
588 BEDRIDDEN 9 0.0007
589 THROMBOSIS 55 0.0007
590 OFF LABEL USE 598 0.0007
591 NIGHT SWEATS 22 0.0007
592 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
593 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
594 DYSURIA 25 0.0007
595 LOWER LIMB FRACTURE 13 0.0007
596 RECTAL HAEMORRHAGE 29 0.0007
597 DEHYDRATION 90 0.0007
598 ATAXIA 8 0.0007
599 HAEMATURIA 23 0.0007
600 POLLAKIURIA 28 0.0007
601 PRODUCT DOSE OMISSION IN ERROR 19 0.0007
602 PYREXIA 232 0.0007
603 CARDIO-RESPIRATORY ARREST 28 0.0007
604 HAEMORRHAGE INTRACRANIAL 10 0.0007
605 HEART RATE INCREASED 66 0.0007
606 HYPOPHAGIA 17 0.0007
607 THYROID CANCER 8 0.0007
608 PRODUCT TASTE ABNORMAL 9 0.0007
609 BLOOD CREATINE PHOSPHOKINASE INCREASED 19 0.0007
610 RESTLESS LEGS SYNDROME 12 0.0007
611 COUGH 185 0.0007
612 ADRENAL INSUFFICIENCY 8 0.0007
613 EXOSTOSIS 6 0.0007
614 PNEUMONIA BACTERIAL 6 0.0007
615 RESPIRATORY DEPRESSION 8 0.0007
616 SWELLING 61 0.0007
617 IRON DEFICIENCY ANAEMIA 6 0.0006
618 GASTRITIS 17 0.0006
619 ANKLE FRACTURE 10 0.0006
620 MASS 9 0.0006
621 ILEUS 8 0.0006
622 DEPRESSED MOOD 34 0.0006
623 PERIPHERAL SWELLING 99 0.0006
624 TASTE DISORDER 13 0.0006
625 DEVICE OCCLUSION 9 0.0006
626 BLOOD SODIUM DECREASED 12 0.0006
627 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
628 TOOTH FRACTURE 7 0.0006
629 CHEST DISCOMFORT 65 0.0006
630 DELIRIUM 22 0.0006
631 PAIN IN EXTREMITY 186 0.0006
632 PNEUMOTHORAX 10 0.0006
633 SWELLING FACE 41 0.0006
634 TOOTH DISORDER 14 0.0006
635 HIP FRACTURE 20 0.0006
636 HEAD DISCOMFORT 11 0.0006
637 ANGER 21 0.0006
638 SKIN LESION 17 0.0006
639 INSOMNIA 163 0.0006
640 KIDNEY INFECTION 12 0.0006
641 VITREOUS FLOATERS 6 0.0006
642 NAUSEA 480 0.0006
643 SINUS DISORDER 12 0.0006
644 HYPERTENSION 128 0.0006
645 HYPERGLYCAEMIA 22 0.0006
646 URTICARIA 101 0.0006
647 ARTHRALGIA 250 0.0006
648 PALPITATIONS 70 0.0006
649 SURGERY 35 0.0006
650 JOINT RANGE OF MOTION DECREASED 8 0.0006
651 INFLUENZA LIKE ILLNESS 49 0.0006
652 HYPOTHERMIA 6 0.0006
653 FEEDING DISORDER 12 0.0006
654 DRY THROAT 6 0.0006
655 HEMIPARESIS 10 0.0006
656 LACTIC ACIDOSIS 19 0.0006
657 DEVICE RELATED INFECTION 9 0.0006
658 SCAR 10 0.0006
659 HEPATOTOXICITY 13 0.0006
660 ABDOMINAL PAIN 135 0.0006
661 PARANOIA 10 0.0006
662 AGGRESSION 29 0.0006
663 CHOLELITHIASIS 19 0.0006
664 VENTRICULAR EXTRASYSTOLES 6 0.0006
665 BASAL CELL CARCINOMA 9 0.0006
666 ACUTE MYOCARDIAL INFARCTION 17 0.0006
667 PANIC ATTACK 21 0.0006
668 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 30 0.0006
669 HAEMOGLOBIN DECREASED 59 0.0006
670 TACHYCARDIA 51 0.0006
671 GASTROOESOPHAGEAL REFLUX DISEASE 46 0.0006
672 SMALL INTESTINAL OBSTRUCTION 7 0.0006
673 SKIN REACTION 8 0.0006
674 DRUG INTERACTION 90 0.0006
675 DEPRESSION 129 0.0006
676 PRODUCT USE IN UNAPPROVED INDICATION 140 0.0006
677 VOMITING 265 0.0006
678 BONE PAIN 33 0.0006
679 RETCHING 12 0.0006
680 TOOTH EXTRACTION 7 0.0006
681 MEMORY IMPAIRMENT 77 0.0006
682 PULMONARY EMBOLISM 53 0.0006
683 CONFUSIONAL STATE 90 0.0006
684 PANCYTOPENIA 31 0.0006
685 PHARYNGITIS STREPTOCOCCAL 6 0.0006
686 BLOOD POTASSIUM INCREASED 9 0.0006
687 BRAIN OEDEMA 7 0.0006
688 TOOTHACHE 10 0.0006
689 INJECTION SITE IRRITATION 7 0.0005
690 ROAD TRAFFIC ACCIDENT 23 0.0005
691 FLUID OVERLOAD 8 0.0005
692 OESOPHAGITIS 6 0.0005
693 SPINAL FRACTURE 11 0.0005
694 FEMUR FRACTURE 17 0.0005
695 ASPARTATE AMINOTRANSFERASE INCREASED 29 0.0005
696 MELAENA 12 0.0005
697 GENERAL PHYSICAL HEALTH DETERIORATION 63 0.0005
698 DYSKINESIA 22 0.0005
699 CARDIOMYOPATHY 8 0.0005
700 HIATUS HERNIA 7 0.0005
701 RASH MACULO-PAPULAR 12 0.0005
702 DEMENTIA 15 0.0005
703 ABDOMINAL DISTENSION 56 0.0005
704 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
705 INTESTINAL PERFORATION 6 0.0005
706 CHROMATURIA 12 0.0005
707 DRY MOUTH 43 0.0005
708 SCAB 6 0.0005
709 INCREASED APPETITE 10 0.0005
710 MALIGNANT MELANOMA 7 0.0005
711 FEELING HOT 32 0.0005
712 QUALITY OF LIFE DECREASED 7 0.0005
713 PULMONARY FIBROSIS 10 0.0005
714 SEIZURE 60 0.0005
715 POST PROCEDURAL HAEMORRHAGE 6 0.0005
716 MUSCULOSKELETAL PAIN 27 0.0005
717 EJECTION FRACTION DECREASED 8 0.0005
718 PALLOR 14 0.0005
719 MENINGIOMA 8 0.0005
720 CARDIAC FAILURE 41 0.0005
721 OROPHARYNGEAL PAIN 47 0.0005
722 SYSTEMIC LUPUS ERYTHEMATOSUS 18 0.0005
723 DISORIENTATION 20 0.0005
724 PAIN 310 0.0005
725 ULCER 8 0.0005
726 HYPOMAGNESAEMIA 7 0.0005
727 MACULAR DEGENERATION 6 0.0005
728 HYPERLIPIDAEMIA 6 0.0005
729 COORDINATION ABNORMAL 7 0.0005
730 BLOOD TEST ABNORMAL 7 0.0005
731 ANAEMIA 95 0.0005
732 TRANSAMINASES INCREASED 11 0.0005
733 HEPATOCELLULAR INJURY 7 0.0005
734 SINUS TACHYCARDIA 7 0.0005
735 NO THERAPEUTIC RESPONSE 6 0.0005
736 ANXIETY 139 0.0005
737 MUSCLE SPASTICITY 6 0.0005
738 IRRITABILITY 29 0.0005
739 DRUG INEFFECTIVE 635 0.0005
740 EPISTAXIS 36 0.0005
741 FREQUENT BOWEL MOVEMENTS 13 0.0005
742 AGEUSIA 12 0.0005
743 SWOLLEN TONGUE 15 0.0005
744 CONSTIPATION 104 0.0005
745 PANCREATITIS 25 0.0005
746 JOINT SWELLING 57 0.0005
747 DRUG EXPOSURE DURING PREGNANCY 16 0.0005
748 CARDIAC DISORDER 44 0.0005
749 COLON CANCER 7 0.0005
750 CIRCULATORY COLLAPSE 8 0.0005
751 HYPOTHYROIDISM 15 0.0005
752 INTRAOCULAR PRESSURE INCREASED 6 0.0005
753 JOINT INJURY 10 0.0005
754 ROTATOR CUFF SYNDROME 6 0.0005
755 BLINDNESS 19 0.0005
756 DECREASED APPETITE 108 0.0005
757 AGITATION 34 0.0005
758 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
759 OSTEOPENIA 7 0.0005
760 EYE PAIN 26 0.0005
761 PLEURAL EFFUSION 28 0.0005
762 PRODUCT PRESCRIBING ISSUE 10 0.0005
763 DISCOMFORT 28 0.0005
764 INJECTION SITE RASH 14 0.0005
765 BLOOD GLUCOSE FLUCTUATION 5 0.0005
766 ALANINE AMINOTRANSFERASE INCREASED 28 0.0005
767 THYROID DISORDER 7 0.0005
768 ADVERSE REACTION 6 0.0005
769 LYMPHADENOPATHY 16 0.0005
770 NERVOUS SYSTEM DISORDER 14 0.0004
771 INJECTION SITE URTICARIA 11 0.0004
772 ENCEPHALOPATHY 11 0.0004
773 ORAL PAIN 10 0.0004
774 ABASIA 11 0.0004
775 ARRHYTHMIA 21 0.0004
776 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
777 UVEITIS 6 0.0004
778 DRY EYE 22 0.0004
779 NERVOUSNESS 23 0.0004
780 GINGIVAL BLEEDING 6 0.0004
781 INJECTION SITE BRUISING 35 0.0004
782 CHEST PAIN 81 0.0004
783 ADVERSE DRUG REACTION 39 0.0004
784 ORAL DISCOMFORT 6 0.0004
785 NEOPLASM PROGRESSION 15 0.0004
786 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
787 LIVER DISORDER 19 0.0004
788 IMPAIRED HEALING 14 0.0004
789 HYPONATRAEMIA 24 0.0004
790 CARDIAC ARREST 35 0.0004
791 FLUSHING 43 0.0004
792 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
793 DISEASE RECURRENCE 20 0.0004
794 SKIN DISORDER 14 0.0004
795 ACCIDENT 5 0.0004
796 OEDEMA PERIPHERAL 51 0.0004
797 HYPOACUSIS 18 0.0004
798 HYPERTHYROIDISM 6 0.0004
799 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
800 SEPTIC SHOCK 18 0.0004
801 DEVICE ISSUE 37 0.0004
802 MENTAL IMPAIRMENT 10 0.0004
803 HYPOGLYCAEMIA 20 0.0004
804 HOT FLUSH 31 0.0004
805 RASH 179 0.0004
806 CEREBRAL INFARCTION 10 0.0004
807 GASTRIC DISORDER 14 0.0004
808 DISTURBANCE IN ATTENTION 22 0.0004
809 BLOOD BILIRUBIN INCREASED 11 0.0004
810 GASTROINTESTINAL HAEMORRHAGE 34 0.0004
811 MOOD ALTERED 11 0.0004
812 OSTEOARTHRITIS 17 0.0004
813 PREGNANCY 8 0.0004
814 HYPERSENSITIVITY 74 0.0004
815 METASTASES TO LIVER 7 0.0004
816 INTESTINAL OBSTRUCTION 15 0.0004
817 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
818 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
819 DRUG DISPENSING ERROR 6 0.0004
820 ADVERSE EVENT 36 0.0004
821 ASTHMA 44 0.0004
822 PERICARDIAL EFFUSION 9 0.0004
823 DYSPEPSIA 38 0.0004
824 TYPE 2 DIABETES MELLITUS 13 0.0004
825 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
826 ACUTE KIDNEY INJURY 59 0.0004
827 DRUG EFFECT INCOMPLETE 14 0.0004
828 PELVIC PAIN 7 0.0004
829 BURNING SENSATION 27 0.0004
830 AMNESIA 25 0.0004
831 ERYTHEMA 78 0.0004
832 OBESITY 6 0.0004
833 JAUNDICE 10 0.0004
834 FLATULENCE 21 0.0004
835 PRURITUS GENERALISED 8 0.0004
836 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
837 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
838 CYTOMEGALOVIRUS INFECTION 6 0.0004
839 MENTAL STATUS CHANGES 10 0.0004
840 EPILEPSY 11 0.0004
841 GLOSSODYNIA 8 0.0004
842 CARPAL TUNNEL SYNDROME 5 0.0004
843 PRODUCT USE ISSUE 67 0.0004
844 PANCREATITIS ACUTE 8 0.0004
845 CANDIDA INFECTION 6 0.0004
846 HAEMATEMESIS 9 0.0004
847 WHEEZING 21 0.0004
848 PRURITUS 136 0.0004
849 DRUG EFFECT DECREASED 19 0.0004
850 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
851 WHITE BLOOD CELL COUNT DECREASED 38 0.0004
852 BRONCHOSPASM 5 0.0004
853 ABORTION SPONTANEOUS 14 0.0003
854 SKIN IRRITATION 16 0.0003
855 RASH GENERALISED 9 0.0003
856 MULTI-ORGAN FAILURE 6 0.0003
857 HAEMATOCHEZIA 19 0.0003
858 BODY TEMPERATURE INCREASED 7 0.0003
859 LABORATORY TEST ABNORMAL 10 0.0003
860 CEREBRAL HAEMORRHAGE 12 0.0003
861 WITHDRAWAL SYNDROME 14 0.0003
862 SYNOVITIS 6 0.0003
863 HEPATIC FAILURE 10 0.0003
864 EYE IRRITATION 19 0.0003
865 BLOOD COUNT ABNORMAL 5 0.0003
866 INJECTION SITE PRURITUS 22 0.0003
867 RESTLESSNESS 12 0.0003
868 IMPAIRED WORK ABILITY 7 0.0003
869 SKIN CANCER 7 0.0003
870 ECZEMA 17 0.0003
871 PRODUCT QUALITY ISSUE 44 0.0003
872 EYE SWELLING 12 0.0003
873 RENAL DISORDER 15 0.0003
874 BLOOD CREATININE INCREASED 21 0.0003
875 MIDDLE INSOMNIA 6 0.0003
876 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
877 NIGHTMARE 11 0.0003
878 PAIN IN JAW 9 0.0003
879 ABDOMINAL PAIN LOWER 8 0.0003
880 RASH MACULAR 11 0.0003
881 INJECTION SITE SWELLING 24 0.0003
882 DISEASE PROGRESSION 37 0.0003
883 INCORRECT DOSE ADMINISTERED 71 0.0003
884 DYSGEUSIA 23 0.0003
885 PRODUCT DOSE OMISSION 20 0.0003
886 ARTHROPATHY 17 0.0003
887 SKIN DISCOLOURATION 14 0.0003
888 INJECTION SITE PAIN 93 0.0003
889 BLOOD CHOLESTEROL INCREASED 14 0.0003
890 COAGULOPATHY 5 0.0003
891 ALOPECIA 58 0.0003
892 BONE MARROW FAILURE 6 0.0003
893 RASH PRURITIC 16 0.0003
894 THROMBOCYTOPENIA 33 0.0003
895 RASH ERYTHEMATOUS 14 0.0003
896 RHEUMATOID ARTHRITIS 33 0.0003
897 PULMONARY HYPERTENSION 6 0.0003
898 CEREBROVASCULAR ACCIDENT 48 0.0003
899 RENAL FAILURE ACUTE 12 0.0003
900 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
901 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 57 0.0003
902 IRRITABLE BOWEL SYNDROME 6 0.0003
903 LIVER FUNCTION TEST INCREASED 6 0.0003
904 DEVICE DISLOCATION 12 0.0003
905 BLOOD GLUCOSE INCREASED 52 0.0003
906 HEPATITIS 7 0.0003
907 EXPOSURE DURING PREGNANCY 17 0.0003
908 ERECTILE DYSFUNCTION 7 0.0003
909 EXTRA DOSE ADMINISTERED 11 0.0003
910 ANAPHYLACTIC SHOCK 7 0.0003
911 INJECTION SITE MASS 10 0.0003
912 NEUTROPHIL COUNT DECREASED 11 0.0003
913 NEOPLASM MALIGNANT 18 0.0003
914 HEPATIC FUNCTION ABNORMAL 10 0.0003
915 DEAFNESS 7 0.0003
916 LUNG NEOPLASM MALIGNANT 11 0.0003
917 SNEEZING 6 0.0003
918 COLITIS 10 0.0003
919 CONVULSION 15 0.0003
920 INJECTION SITE REACTION 18 0.0003
921 TINNITUS 12 0.0003
922 CHOLESTASIS 5 0.0003
923 UNDERDOSE 19 0.0003
924 NO ADVERSE EVENT 47 0.0003
925 VAGINAL HAEMORRHAGE 11 0.0003
926 MENTAL DISORDER 11 0.0003
927 MYOCARDIAL INFARCTION 44 0.0003
928 HAEMOPTYSIS 7 0.0003
929 METABOLIC ACIDOSIS 8 0.0002
930 RENAL IMPAIRMENT 21 0.0002
931 BLOOD GLUCOSE DECREASED 12 0.0002
932 MULTIPLE SCLEROSIS RELAPSE 17 0.0002
933 FEBRILE NEUTROPENIA 16 0.0002
934 DRUG ABUSE 20 0.0002
935 INTENTIONAL PRODUCT MISUSE 21 0.0002
936 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
937 RENAL FAILURE 31 0.0002
938 TREATMENT FAILURE 19 0.0002
939 INJURY 16 0.0002
940 INTERSTITIAL LUNG DISEASE 11 0.0002
941 APPLICATION SITE PAIN 5 0.0002
942 ANGIOEDEMA 10 0.0002
943 INJECTION SITE ERYTHEMA 28 0.0002
944 PULMONARY OEDEMA 10 0.0002
945 DRUG-INDUCED LIVER INJURY 7 0.0002
946 PAIN OF SKIN 6 0.0002
947 DEATH 191 0.0002
948 ACCIDENTAL OVERDOSE 8 0.0002
949 PLATELET COUNT DECREASED 23 0.0002
950 STOMATITIS 13 0.0002
951 BLISTER 12 0.0002
952 OCULAR HYPERAEMIA 10 0.0002
953 HAEMORRHAGE 22 0.0002
954 EMOTIONAL DISTRESS 25 0.0002
955 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
956 ABNORMAL BEHAVIOUR 8 0.0002
957 INJECTION SITE HAEMORRHAGE 16 0.0002
958 PSORIATIC ARTHROPATHY 8 0.0002
959 CRYING 7 0.0002
960 INTENTIONAL OVERDOSE 12 0.0002
961 CARDIAC FAILURE CONGESTIVE 15 0.0002
962 OSTEONECROSIS 6 0.0002
963 VISUAL ACUITY REDUCED 6 0.0002
964 EXPIRED PRODUCT ADMINISTERED 6 0.0002
965 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
966 OVERDOSE 38 0.0002
967 DEVICE USE ERROR 6 0.0002
968 DEVICE BREAKAGE 7 0.0002
969 RHABDOMYOLYSIS 7 0.0002
970 MULTIPLE SCLEROSIS 8 0.0002
971 TOXICITY TO VARIOUS AGENTS 28 0.0002
972 SKIN EXFOLIATION 14 0.0002
973 SUICIDAL IDEATION 15 0.0002
974 SUICIDE ATTEMPT 9 0.0001
975 DRUG DOSE OMISSION 24 0.0001
976 CHRONIC KIDNEY DISEASE 11 0.0001
977 SKIN BURNING SENSATION 10 0.0001
978 DRUG DEPENDENCE 21 0.0001
979 PROSTATE CANCER 10 0.0001
980 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
981 DEVICE DIFFICULT TO USE 8 0.0001
982 DRY SKIN 16 0.0001
983 ACNE 9 0.0001
984 PSORIASIS 15 0.0001
985 PRODUCT STORAGE ERROR 10 0.0001
986 DEVICE MALFUNCTION 8 0.0001
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
988 NEUTROPENIA 15 0.0001
989 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
990 BREAST CANCER 10 0.0001
991 DRUG DOSE OMISSION BY DEVICE 6 0.0001
992 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001